Skip to main content
. Author manuscript; available in PMC: 2021 Aug 28.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2020 May 18;30(9):1500–1511. doi: 10.1016/j.numecd.2020.05.001

Figure 1. Significant gut-enterotype interactions on the association between dietary soy intake and metabolites in plasma (A, B), Stool (C), and Systolic Blood Pressure (D).

Figure 1

Data shown for short-term soy intake. Results for long-term soy intake were almost identical. All interactions p < 0.05. While there were no associations between soy and outcomes within enterotype 2, individuals had lower plasma 2-hydroxybutyrate, higher plasma glycine, higher stool liquiritigenin, and lower systolic blood pressure with increasing soy intake.